Category Archives: Healthcare

Biolinerx Received its Third Buy in a Row

After Maxim Group and Oppenheimer assigned a Buy rating to Biolinerx in the last month, the company received another Buy, this time from H.C. Wainwright. Analyst Joseph Pantginis reiterated a Buy rating on Biolinerx (NASDAQ: BLRX) today and set a

Tuesday’s Highlights at Noon: Northwest Biotherapeutics (NWBO), Cytokinetics Inc (CYTK), Growlife Inc (PHOT), Microvision (MVIS), Himax Technologies (HIMX)

So far Tuesday, November 21, NASDAQ is up 0.87% and the S&P is up 0.81%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Northwest Biotherapeutics (NASDAQ:NWBO), Cytokinetics Inc (NASDAQ:CYTK), Growlife Inc (Other OTC:PHOT),

Canaccord Genuity Thinks Aquinox Pharmaceuticals’ Stock is Going to Recover

Canaccord Genuity analyst Arlinda Lee reiterated a Buy rating on Aquinox Pharmaceuticals (NASDAQ: AQXP) yesterday and set a price target of $22. The company’s shares opened today at $10.61, close to its 52-week low of $10.20. According to TipRanks.com, Lee

Align Tech Receives a Buy from Stifel Nicolaus

Stifel Nicolaus analyst Jonathan Block reiterated a Buy rating on Align Tech (NASDAQ: ALGN) today and set a price target of $265. The company’s shares closed yesterday at $255.51, close to its 52-week high of $258.61. According to TipRanks.com, Block

H.C. Wainwright Believes Cytosorbents Corp (NASDAQ: CTSO) Won’t Stop Here

H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on Cytosorbents Corp (NASDAQ: CTSO) today and set a price target of $13. The company’s shares closed yesterday at $6.50, close to its 52-week high of $6.70. According to TipRanks.com, Ramakanth

Histogenics Receives a Buy from H.C. Wainwright

In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Histogenics (NASDAQ: HSGX), with a price target of $3.50. The company’s shares closed yesterday at $1.99. According to TipRanks.com, Ramakanth is ranked 0 out of